13F Pro13F Pro

RICE HALL JAMES & ASSOCIATES, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1230765
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare33.3%$683.2M
  • Technology30.1%$617.9M
  • Industrials18.6%$382.1M
  • Consumer Discretionary6.0%$122.5M
  • Communication Services3.8%$77.0M
  • Financials3.4%$70.4M
  • Materials1.9%$39.7M
  • Energy1.4%$28.6M
  • Other0.8%$17.4M
  • Consumer Staples0.8%$15.7M

AUM History

13fpro.ai/research/fund/rice-hall-james-and-associates-llc-1230765

Conviction and streaks

Stable · top 10 = 24.1%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/rice-hall-james-and-associates-llc-1230765

RICE HALL JAMES & ASSOCIATES, LLC 13F holdings — Q2 2026

$2.1B portfolio (+14.4% QoQ) · 240 holdings · Q2 2026 13F · top 10 are 24% of the stock portfolio

All holdings — RICE HALL JAMES & ASSOCIATES, LLC (Q2 2026)

240 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
LRN$LRNStride, Inc.$37.9M+0.1%
PBH$PBHPrestige Consumer Healthcare Inc.$32.6M+32%
DFIN$DFINDonnelley Financial Solutions, Inc.$32.5M-0.6%
ITRN$ITRNIturan Location & Control Ltd.$29.0M-11%
MEDP$MEDPMedpace Holdings, Inc.$28.7M+0.2%
AWI$AWIARMSTRONG WORLD INDUSTRIES INC$28.4M+0.2%
GDDY$GDDYGoDaddy Inc.$28.1M+3%
BIRK$BIRKBirkenstock Holding plc$27.1M+7%
YOU$YOUClear Secure, Inc.$27.0M-16%
NGVT$NGVTIngevity Corp$26.2M+2%
WEX$WEXWEX Inc.$25.2M-0.9%
SRAD$SRADSportradar Group AG$23.9M+1.0%
LQDT$LQDTLIQUIDITY SERVICES INC$23.8M+2%
AGM$AGMFEDERAL AGRICULTURAL MORTGAGE CORP$23.5M+3%
BCRX$BCRXBIOCRYST PHARMACEUTICALS INC$23.3M+5%

What changed in Q2 2026

Against the previous quarter's 13F: 12 new, 111 added to, 102 trimmed, 15 sold out. Share-count changes; largest moves by dollar size first.

New positions (12)

  • OSK$OSKOSHKOSH CORP$16.3M

    first bought this quarter

  • PAR$PARPAR TECHNOLOGY CORP$6.6M

    first bought this quarter

  • SHLS$SHLSShoals Technologies Group, Inc.$6.4M

    first bought this quarter

  • ATEC$ATECAlphatec Holdings, Inc.$5.7M

    first bought this quarter

  • CECO$CECOCECO ENVIRONMENTAL CORP$3.5M

    first bought this quarter

  • BMI$BMIBADGER METER INC$3.0M

    first bought this quarter

+6 more in the Excel export

Added to (111)

  • UPWK$UPWKUPWORK, INC+112%

    now $23.2M · held 2 qtrs, 2 adds in a row

  • TTI$TTITETRA TECHNOLOGIES INC+2582%

    now $12.1M · held 2 qtrs, 2 adds in a row

  • BMRN$BMRNBIOMARIN PHARMACEUTICAL INC+137%

    now $14.2M · held 10+ qtrs, 2 adds in a row

  • PBH$PBHPrestige Consumer Healthcare Inc.+32%

    now $32.6M · held 10+ qtrs, 2 adds in a row

  • VRDN$VRDNViridian Therapeutics, Inc.\DE+31%

    now $21.6M · held 7 qtrs, 7 adds in a row

  • LCII$LCIILCI INDUSTRIES+35%

    now $15.1M · held 10+ qtrs, 3 adds in a row

+105 more in the Excel export

Trimmed (102)

  • AEHR$AEHRAEHR TEST SYSTEMS-68%

    now $8.4M · held 10+ qtrs, 2 trims in a row

  • CEVA$CEVACEVA INC-77%

    now $4.6M · held 10+ qtrs

  • FN$FNFabrinet-17%

    now $49.2M · held 10+ qtrs

  • GTLS$GTLSCHART INDUSTRIES INC-48%

    now $7.9M · held 6 qtrs, 4 trims in a row

  • AAOI$AAOIAPPLIED OPTOELECTRONICS, INC.-43%

    now $8.3M · held 10+ qtrs, 4 trims in a row

  • ICHR$ICHRICHOR HOLDINGS, LTD.-32%

    now $11.7M · held 4 qtrs, 3 trims in a row

+96 more in the Excel export

Sold out (15)

  • FOLD$FOLDAMICUS THERAPEUTICS, INC.was $11.1M

    held 9+ qtrs

  • SLNO$SLNOSOLENO THERAPEUTICS INCwas $6.9M

    held 1 qtr

  • AMPH$AMPHAmphastar Pharmaceuticals, Inc.was $3.7M

    held 3 qtrs

  • VITL$VITLVital Farms, Inc.was $3.1M

    held 9+ qtrs

  • THR$THRThermon Group Holdings, Inc.was $2.9M
  • ADMA$ADMAADMA BIOLOGICS, INC.was $2.7M

+9 more in the Excel export

Firm AUM (Form ADV): $1.7B as of 2025-12-31 · SEC IAPD

Holdings by quarter

Every 13F RICE HALL JAMES & ASSOCIATES, LLC has filed, 36 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow RICE HALL JAMES & ASSOCIATES?

Q2 2026 13F filed with the SEC on Aug 7, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of RICE HALL JAMES & ASSOCIATES's top 20 holdings: 60/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)

Top 10 since filing

-8.1%

Value-weighted move of the 10 largest stock positions

Turnover

8%

Last quarter; 32% over the last 4

Top 10 weight

24%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

92%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

RICE HALL JAMES & ASSOCIATES, LLC disclosed 240 positions worth $2.1B in its Form 13F-HR for Q2 2026, led by $LGND (LIGAND PHARMACEUTICALS INC) at 4.2% of the equity portfolio, followed by $ACIW and $ARLO. During the quarter the fund opened 12 new positions and exited 15 — including a new stake in $OSK and a full exit from $FOLD. The portfolio is most concentrated in Healthcare (33.3% of disclosed assets). All figures are sourced directly from RICE HALL JAMES & ASSOCIATES, LLC’s Form 13F-HR filing with the SEC under CIK 1230765.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: RICE HALL JAMES & ASSOCIATES, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For RICE HALL JAMES & ASSOCIATES, LLC (SEC CIK: 1230765), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in RICE HALL JAMES & ASSOCIATES, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.